pharmaceutical care untuk penyakit hipertensi - Binfar Depkes

24. Parving HH et al. The Effect Of Irbesartan On The Development Of DiabeticNephropathy In Patients With Type 2 Diabetes. N Eng J Med 2001;345:870-87825. Wright JT Jr et al. Effect Of Blood Pressure Lowering And AntihypertensiveDrug Class On Progression Of Hypertensive Kidney Disease:Results from theAASK trial. JAMA 2002;288:2421-243126. Bakris GL et al. Angiotensin-Converting-Enzyne-Inhibitor-AssociatedElevations In Serum Creatinine. Arch Intern Med 2000;160:685-69327. Gijn JV. The PROGRESS Trial: Preventing Stroke by Lowering BloodPressure in Patients with Cerebral Ischemia. Stroke 2002;33:31928. Haynes RB et al. Helping Patients Follow Prescribed Treatment. JAMA2002;288:2880-288329. Benson J et al. Patient’s Decision About Whether or Not To TakeAntihypertensive Drugs: qualitative study. BMJ 2002;325:873-87830. Thrift AG et al. Three Important Subgroups Of Hypertensive Persons AtGreater Risk Of Intracerebral Hemorrhage. Hypertension 1998;31:1223-122931. Haynes RB et al. Interventions To Enhance Patients’ Adherence ToMedication Prescription. JAMA 2002;288:2868-7932. Deedwania PC. The Progression from Hypertension to Heart Failure. AJH1997;10:280S-288S33. Zillich AJ et al. ASHP Therapeutic Position Statement on the Treatment ofHypertension. Am J Health-Syst Pharm 2006;63:1074-108034. Carter BL et al. Evaluation of Hypertensive Patients after Care Provided byCommunity Pharmacists in a Rural Setting. Pharmacotherapy1997;17(6):1274-1285. Abstract35. Piepho RW. Overview The Angiotensin-Converting-Enzyme-Inhibitor. Am JHealth- Syst Pharm 2000;57(Suppl 1):S3-736. Carter BL et al. How Pharmacist Can Assist Physicians with ControllingBlood Pressure. J Clin Hypertens 2003;5(1):31-3737. ALLHAT Officers and Coordinators for the ALLHAT CoolaborativeResearch Group. Major Outcomes in high-risk hypertensive patientsrandomized to angiotensin-converting enzyme inhibitor or calcium channelblocker vs diuretic. The Antihypertensive and Lipid-Lowering Treatment toPrevent Heart Attack Trial. JAMA 2002;288:2981-2997